Real ChatGPT answer · index seedQScJqXMq12kcompleteHealth and wellness · pharmacies and prescriptionscommercial
What are the current Medicare Part D tier changes for preferred brand-name anticoagulants this year and how do I appeal a tier placement?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the current Medicare Part D tier changes for preferred brand-name anticoagulants this year and how do I appeal a tier placement?
3 real searches · 1 real-search pass
2026 Medicare Part D formulary tier changes preferred brand anticoagulants Eliquis Xarelto CMS 2026Google ↗
OBSERVED
Medicare Part D 2026 tiering exception appeal process coverage determination formulary exception CMS Medicare.govGoogle ↗
OBSERVED
2026 Medicare Part D out of pocket cap $2100 insulin negotiated prices Eliquis anticoagulantsGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 Medicare Part D formulary tier changes preferred brand anticoagulants Eliquis Xarelto CMS 2026 Google ↗
Medicare Part D 2026 tiering exception appeal process coverage determination formulary exception CMS Medicare.gov Google ↗
2026 Medicare Part D out of pocket cap $2100 insulin negotiated prices Eliquis anticoagulants Google ↗
- Final CY 2026 Part D Redesign Program Instructions · cms.gov
- Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026 · kff.org
- Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 · cms.gov
- Pricing Information | Rx ELIQUIS® (apixaban) · eliquis.bmscustomerconnect.com
- Exceptions · cms.gov
- 42 CFR § 423.578 - Exceptions process. | Electronic Code of Federal Regulations (e-CFR) | US Law · law.cornell.edu
- Coverage Determinations · cms.gov
- Redetermination by the Part D Plan Sponsor · cms.gov
- Appeals Overview · cms.gov
- Medicare: Understanding drug tiers and exceptions · medicare.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 Medicare Part D formulary tier changes preferred brand anticoagulants Eliquis Xarelto CMS 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Medicare Part D 2026 tiering exception appeal process coverage determination formulary exception CMS Medicare.gov OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2026 Medicare Part D out of pocket cap $2100 insulin negotiated prices Eliquis anticoagulants OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |